thiouracil and Leukemia--Promyelocytic--Acute

thiouracil has been researched along with Leukemia--Promyelocytic--Acute* in 1 studies

Other Studies

1 other study(ies) available for thiouracil and Leukemia--Promyelocytic--Acute

Article	Year
Ruthenium(II) complexes with 6-methyl-2-thiouracil selectively reduce cell proliferation, cause DNA double-strand break and trigger caspase-mediated apoptosis through JNK/p38 pathways in human acute promyelocytic leukemia cells. Scientific reports, 2019, 08-07, Volume: 9, Issue:1 Topics: Animals; Apoptosis; Caspases; Cell Proliferation; Coordination Complexes; DNA Breaks, Double-Stranded; Female; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; MAP Kinase Signaling System; Mice; Phosphorylation; Ruthenium; Thiouracil; Xenograft Model Antitumor Assays	2019

Article

Year

Ruthenium(II) complexes with 6-methyl-2-thiouracil selectively reduce cell proliferation, cause DNA double-strand break and trigger caspase-mediated apoptosis through JNK/p38 pathways in human acute promyelocytic leukemia cells.

Scientific reports, 2019, 08-07, Volume: 9, Issue:1

Topics: Animals; Apoptosis; Caspases; Cell Proliferation; Coordination Complexes; DNA Breaks, Double-Stranded; Female; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; MAP Kinase Signaling System; Mice; Phosphorylation; Ruthenium; Thiouracil; Xenograft Model Antitumor Assays

2019